• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Combined patient and provider intervention associated with improvement in osteoarthritis management in veterans

byCaitlyn HuiandSai Folmsbee
December 22, 2015
in Chronic Disease
Reading Time: 3 mins read
Placebo formulation impacts effectiveness of pain control in osteoarthritis
Share on FacebookShare on Twitter

1. From a randomized clinical trial, intervention at both the patient and provider level showed modest improvement in osteoarthritis management of patient function and physical activity when compared to control subjects.

2. Depressive symptoms, BMI, and pain scores of patients were not significantly affected by interventional methods.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Osteoarthritis is an increasingly prevalent cause of chronic illness, pain, and disability. While evidence-based guidelines indicate the importance of clinical strategies and behavioral changes in improving osteoarthritis outcomes, many clinical strategies are underused and a large proportion of patients are physically inactive or overweight. The purpose of this study was to examine the effects of combined patient and provider intervention in improving osteoarthritis management and improving overall patient outcomes. This study involved veterans enrolled in the Durham Veteran Association (VA) Medical Center and 30 of the center’s primary care providers. The patient’s primary outcome was assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Notably, a moderate improvement in total WOMAC scores was observed in the osteoarthritis intervention group, while the control group remained around baseline levels. Clinically meaningful improvements in WOMAC scores have typically ranged from 12% to 18%, rather than the 8.5% observed in this trial. However, due to the design of this trial, it is not possible to determine the individual effects of patient and provider intervention, thereby limiting the analysis of the efficacy of these measures. Additionally, there may be limited generalizability of the study, as the patients receiving care at the VA medical center were mostly male. However, this study provides evidence that patient and provider intervention may improve the management of osteoarthritis.

Click to read the study published today in the Annals of Internal Medicine

Relevant Reading: Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial.

RELATED REPORTS

Joint fusion superior to watchful waiting for hallux rigidus 

Glucosamine Linked to Faster Alzheimer’s Progression in Patients with Mild Cognitive Impairment

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

In-Depth [randomized controlled trial]: The trial identified patients with hip osteoarthritis, knee osteoarthritis, or both, in addition to patients that were overweight (BMI ≥ 25 kg/m2), not adhering to physical activity recommendations (U.S. Department of Health and Human Services), and reported joint symptoms. Participants then were randomly assigned to either the control (i.e., patients received their usual care) or osteoarthritis intervention group. Patient intervention involved telephone calls aimed at improving patient physical activity, weight management, and goal setting over the course of 12 months, while provider intervention included patient-specific osteoarthritis treatment recommendations according to a developed algorithm based on published treatment guidelines. At the conclusion of the study, the estimated mean change in total WOMAC score was –4.0 points (95%CI –6.2 to –1.8 points) in the osteoarthritis intervention group and 0.1 points (95%CI –2.3 to 2.3 points) in the control group. Furthermore, the estimated mean difference between groups was –4.1 (95%CI –7.2 to –1.1 points, p = 0.009). In secondary outcome analysis, no significant differences were observed between groups for BMI, WOMAC pain subscale score, or depressive symptoms; however, improvements were observed in changes to exercise from baseline physical activity and WOMAC function subscale score.

Image: CC/Wiki

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: osteoarthritis
Previous Post

Kangaroo mother care linked to better neonatal outcomes

Next Post

Nutritional support amongst medical inpatients offers limited clinical benefit

RelatedReports

Uninterrupted warfarin therapy safe for endovascular procedures
Orthopedic Surgery

Joint fusion superior to watchful waiting for hallux rigidus 

August 10, 2026
Amyloid may cause distant cerebral hypometabolism in Alzheimer’s
Psychiatry

Glucosamine Linked to Faster Alzheimer’s Progression in Patients with Mild Cognitive Impairment

September 4, 2026
Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

May 21, 2026
#VisualAbstract: Personalised Gait Retraining is an Effective Non-Surgical Treatment for Medial Compartment Knee Osteoarthritis
StudyGraphics

#VisualAbstract: Personalised Gait Retraining is an Effective Non-Surgical Treatment for Medial Compartment Knee Osteoarthritis

August 25, 2025
Next Post
Parent/child feeding practices associated with weight status

Nutritional support amongst medical inpatients offers limited clinical benefit

Turtle-associated salmonellosis reemerging as pediatric public health issue

Turtle-associated salmonellosis reemerging as pediatric public health issue

Prescription of antibiotics for acute respiratory infections increasing

Delayed antibiotic prescribing for respiratory infections may decrease unnecessary antibiotic use

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
  • Real-time AI guidance enters live brain tumor surgery
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.